Tissue plasminogen activator (tPA) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter?
Niels Willem Boone, Roelof Wouter Frederik van LeeuwenMaastricht University Medical Centre, Department of Clinical Pharmacy and Toxicology, Maastricht, The NetherlandsRecently our hospital pharmacy, which serves an academic hospital with an internationally well-known department of ophthalmology, rec...
Enregistré dans:
Auteurs principaux: | Boone NW, van Leeuwen RWF |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/43edcb1ca8cf4cafa08fd527b225072a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration
par: Luis Arias, et autres
Publié: (2010) -
Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab
par: Sukhpal Singh Sandhu, et autres
Publié: (2010) -
An origami paper-based nanoformulated immunosensor detects picograms of VEGF-C per milliliter of blood
par: Shuai Sun, et autres
Publié: (2021) -
Case–control diagnostic accuracy study of a non-sputum CD38-based TAM-TB test from a single milliliter of blood
par: Hellen Hiza, et autres
Publié: (2021) -
Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA.
par: Mitsunori Ishiguro, et autres
Publié: (2010)